Lymphocyte T-Cell Immunomodulator (LTCI) presents a revolutionary, USDA-approved treatment option for osteoarthritis in dogs. In a pivotal clinical trial, over 90% of LTCI patients achieved …

LTCI is the first and only USDA-approved treatment aid for cats infected with Feline Leukemia Virus (FeLV) and/or Feline Immunodeficiency Virus (FIV). And now, LTCI is the first USDA …

LTCI, a naturally-occurring biologic, is the first USDA-approved immune modulator for treating canine osteoarthritis. Osteoarthritis–as an immune-mediated disease–should be treated as such.

2011年5月31日 · Veterinarians may now order Lymphocyte T-Cell Immunomodulator (LTCI) -- reportedly the first United States Department of Agriculture (USDA) approved treatment for …

T-Cyte Therapeutics provides USDA-approved, innovative treatment solutions that safely address the needs of pets with immune-mediated diseases, such as osteoarthritis. T-Cyte is dedicated …

2014年5月21日 · T-Cyte Treatment is treating cats who have FeLV and/or FIV with Lymphocyte T-Cell Immunomodulator. T-Cyte Therapeutics is the name of the manufacturer who supply …

2016年10月6日 · T-Cyte Therapeutics, Inc., today announces the U.S. launch of Lymphocyte T-Cell Immunomodulator (LTCI) as the first USDA-approved treatment option for canine …

2016年10月5日 · MURRIETA, CA-- (Marketwired - Oct 5, 2016) - T-Cyte Therapeutics, Inc., today announces the U.S. launch of Lymphocyte T-Cell Immunomodulator (LTCI) as the first USDA …

2016年10月6日 · Now, T-Cyte provides the only treatment aid for cats infected with FeLV and FIV and has expanded its treatment options to canines, with LTCI functioning as the first USDA …

As a naturally-occurring, immune-modulating protein, LTCI is the first USDA-approved treatment aid for osteoarthritis in dogs. The long prevailing understanding of osteoarthritis (OA) has been …